The abstract is read at the publisher; the summary is JClub's.
Cartilage-specific loss of Irf2bp2 in osteoarthritis mouse models elevates SOX9 and attenuates OA progression, enhancing cartilage regeneration and hyalinization.
- Why it matters: OA cartilage degeneration lacks clear molecular explanations, limiting targeted therapies that could preserve cartilage integrity and restore chondrocyte differentiation.
- What they did: The study used Irf2bp2 deficiency and cartilage-specific knockout in DMM and microfracture models, plus mechanistic assays showing IRF2BP2 binds and stabilizes FOSL2 to repress SOX9.
- The result: AAV-mediated FOSL2 overexpression reversed Irf2bp2-deficient protection, while AAV IRF2BP2 knockdown, T-5224 targeting of the IRF2BP2/AP-1 axis, and intra-articular delivery of an IRF2BP2–FOSL2 binding–disrupting peptide preserved cartilage integrity.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.